CNS Treatments
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
177
NCT05148884
Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 9, 2021
Completion: Jan 18, 2023
NCT05287997
Blood Biomarker Study to Diagnose Adolescent Sport Concussion
Phase: N/A
Start: Jun 1, 2022
Completion: Dec 31, 2023
Loading map...